COMMUNIQUÉ DE PRESSE publié le 17/01/2024 à 12:00, il y a 2 années 5 mois UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com. UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval
Publié le 08/07/2026 à 18:00, il y a 13 minutes 464 M€ DE NOUVEAUX FINANCEMENTS POUR SOUTENIR LA CROISSANCE DE FREY
Publié le 08/07/2026 à 18:00, il y a 13 minutes €464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Publié le 08/07/2026 à 17:45, il y a 28 minutes COGRA : CHIFFRE D’AFFAIRES DE L'EXERCICE 2025/26 : 42,4 M€ +24%
Publié le 08/07/2026 à 15:25, il y a 2 heures 48 minutes Rockhaven Announces Granting of Incentive Stock Options
Publié le 08/07/2026 à 15:00, il y a 3 heures 13 minutes Karbon-X Announces Strategic Partnership to Evaluate Kenya BioHub Initiative
Publié le 08/07/2026 à 15:00, il y a 3 heures 13 minutes GameSquare's Stream Hatchet Publishes Esports Live Streaming Trends Report
Publié le 08/07/2026 à 14:30, il y a 3 heures 43 minutes Research Analyst Report on NanoViricides Rates Company "Outperform"; Separately, A "Fireside Chat" Interview of the Company's President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily
Publié le 08/07/2026 à 18:03, il y a 9 minutes Kontron AG: The Executive Board and Supervisory Board recommend that shareholders do not accept the mandatory takeover offer from Ennoconn Corporation
Publié le 08/07/2026 à 15:42, il y a 2 heures 30 minutes EQS-Adhoc: Kapsch TrafficCom signs agreement on the sale of a majority stake in German subsidiary and is therefore expecting a significant impact on EBIT.
Publié le 08/07/2026 à 15:22, il y a 2 heures 51 minutes Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Publié le 08/07/2026 à 15:21, il y a 2 heures 51 minutes Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Publié le 08/07/2026 à 15:21, il y a 2 heures 52 minutes Form 8.3 - The Vanguard Group, Inc.: Senior plc